Huntington's disease: Neural dysfunction linked to inositol polyphosphate multikinase

Area of Science:

• Neuroscience
• Molecular Biology
• Genetics

Background:

• Huntington's disease (HD) is a progressive neurodegenerative disorder.
• The disease is caused by a mutation in the huntingtin gene, leading to an expanded CAG repeat.
• The exact pathophysiology of HD remains unclear.

Purpose of the Study:

• To investigate the role of inositol polyphosphate multikinase (IPMK) in Huntington's disease.
• To explore the relationship between IPMK, mutant huntingtin (mHtt), and neural dysfunction in HD.

Main Methods:

• Examined IPMK levels in HD patients' striatum and HD cellular/animal models.
• Investigated the effect of mHtt on IPMK expression via COUP-TF-interacting protein 2 (Ctip2).
• Assessed the impact of IPMK modulation on HD cellular and animal models.

Main Results:

• A significant reduction in IPMK was observed in the striatum of HD patients and models.
• Mutant huntingtin (mHtt) impairs Ctip2, a transcription factor regulating IPMK.
• IPMK overexpression ameliorated metabolic deficits in HD cells.
• Intrastriatal IPMK delivery reduced motor abnormalities and striatal pathology in HD mice.

Conclusions:

• IPMK depletion is a key feature of HD pathophysiology.
• Restoring IPMK levels can reverse metabolic deficits and mitigate motor symptoms in HD models.
• Targeting IPMK presents a potential therapeutic strategy for Huntington's disease.